Viewing Study NCT02341495


Ignite Creation Date: 2025-12-24 @ 1:12 PM
Ignite Modification Date: 2026-01-12 @ 6:28 AM
Study NCT ID: NCT02341495
Status: TERMINATED
Last Update Posted: 2020-02-27
First Post: 2013-09-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65
Sponsor: Elizabeth Henry
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Azacitidine View
None Vidaza View
None Deferasirox View
None Exjade View
None Cholecalciferol View
None Vitamin D View